U.S. researchers conducted a retrospective study involving 372 patients with C. diff, between the ages of 11 months and 23 years. The study participants underwent an FMT procedure at a pediatric center in the U.S. The FMT was administered via colonoscopy, nasogastric tube, frozen capsules or enemas.
After analyzing two-month outcomes for 335 patients, researchers found that 81 percent of the patients did not experience a recurrence of C. diff after one FMT treatment. Of the remaining patients who had two rounds of FMT, about 50 percent did not have C. diff recurrence. The overall success rate was 87 percent.
Researchers also found that success of the FMT procedures was 2.4 times more likely when patients received the stool via colonoscopy compared to other methods.
Researchers said that the study was limited by its retrospective design and relatively short period of follow-up.
More articles on healthcare quality:
Better patient experience, employee engagement can boost hospital finances
Health officials investigate Illinois hospital treating baby cut from woman’s womb
NIH suspended Duke’s research grants over safety concerns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.